Skip to content
DeepTek logo — Radiology AI in Action

DeepTek

Radiology AI in Action

Founded 2017 United States New York, United States 107 employees Series A Total: $770.00M AI, Health Care +1

General Information

Company Name DeepTek
Founded Year 2017
Location United States New York, United States
Employees 107
Industries AI, Health Care, Machine Learning
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with DeepTek. To contact DeepTek, visit deeptek.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does DeepTek compare?

A PDF of DeepTek and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting DeepTek soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About DeepTek

DeepTek is a healthcare startup founded in 2017 with headquarters in the United States. The company's slogan, "Radiology AI in Action," reflects its focus on leveraging cutting-edge AI and machine learning technologies to develop an advanced decision support system for radiologists. DeepTek's solutions are designed to reduce radiologists' workload and expedite the diagnosis process. The startup has made significant strides in its presence in India, forging partnerships with several hospitals and medical institutes. Its most recent milestone is the INR770.00M Series A investment on 07 March 2022, which saw participation from prominent investors such as GHV Accelerator, Tata Capital, and Pentathlon Ventures. This signifies a strong investor interest in the potential of DeepTek's innovative solutions within the radiology AI space.

Business keywords: radiology, decision support system, radiologists, workload reduction, diagnosis process, medical imaging, partnerships, hospitals, medical institutes

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A INR770.00M 3
GHV Accelerator, Tata Capital +1
07 Mar 2022
Venture Round Undisclosed 4
GHV Accelerator, Pentathlon Ventures +2
15 May 2020
Corporate Round Undisclosed 1
NTT Data
09 Oct 2018

DeepTek Alternatives & Competitors

View All Alternatives
DeepTek vs
Oxipit
Oxipit Lithuania

Leading the way with the world's first autonomous radiology AI

Seed
21 employees
AI, Computer Vision
DeepTek vs

AI and Deep Learning in cancer diagnosis #pathology #oncology #radiology

6 employees
Analytics, Computer Vision
DeepTek vs
Envisionit Deep AI®
Envisionit Deep AI® United Kingdom

An innovative medical technology company that uses AI to streamline & improve medical imaging diagno...

Seed
11 employees
AI, Health Care

FAQ About DeepTek

Radiology AI in Action
DeepTek was founded in 2017.
DeepTek is headquartered in New York, United States.
DeepTek operates in AI, Health Care and Machine Learning. Its work centres on radiology, decision support system, radiologists and workload reduction.
DeepTek has approximately 107 employees.
DeepTek has completed 3 funding rounds, raising a total of $770.00M. The latest funding stage is Series A.
Top alternatives and competitors to DeepTek include Oxipit, CancerCenter.ai, Envisionit Deep AI®, MICA AI Medical, Botkin.AI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DeepTek and Oxipit are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for DeepTek, https://www.bouncewatch.com/company/deeptek, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout